Compounds and compositions as ITPKb inhibitors

Details for Australian Patent Application No. 2007275049 (hide)

Owner IRM LLC

Inventors Yang, Yang; Pan, Shifeng; Xie, Yun Feng; Bursulaya, Badry; Chamberlain, Philip; Han, Dong; Karanewsky, Donald S.; Wan, Yongqin; Liu, Yi; Jiang, Jiqing; Gao, Wenqi; Cheng, Dai; Wang, Xia

Agent Davies Collison Cave

Pub. Number AU-B-2007275049

PCT Pub. Number WO2008/011611

Priority 60/893,874 08.03.07 US; 60/832,681 21.07.06 US

Filing date 20 July 2007

Wipo publication date 24 January 2008

Acceptance publication date 3 March 2011

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/011611 Priority application(s): WO2008/011611

3 March 2011 Application Accepted

  Published as AU-B-2007275049

30 June 2011 Standard Patent Sealed

2 August 2012 Offer to Surrender

  IRM LLC 131 Front Street , P.O. Box HM 2899 , the Patentee of Letters Patent 2007275049 dated 16.06.2011 for an invention titled ' Compounds and compositions as ITPKb inhibitors' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

20 September 2012 Offer to Surrender

  The offer by the Patentee IRM LLC to surrender Letters Patent 2007275049 which was advertised in the Official Journal Revocation of 02.08.2012 has been accepted and the Letters Patent has been revoked in accordance with Section 137 of the Patents Act.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275067-Macrocyclic compounds useful as BACE inhibitors

2007275048-Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion